Yuzo Watanabe

发表

Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study

S. Fukuhara, M. Iwasaki, S. Morita, 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Japanese Society for Dialysis Therapy Clinical Guideline for “Maintenance Hemodialysis: Hemodialysis Prescriptions”

K. Tabei, S. Nakai, J. Minakuchi, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Shared decision making for the initiation and continuation of dialysis: a proposal from the Japanese Society for Dialysis Therapy

J. Minakuchi, K. Tsuchiya, K. Tsuruya, 2021, Renal Replacement Therapy.

Low Hemoglobin Levels and Hypo‐Responsiveness to Erythropoiesis‐Stimulating Agent Associated With Poor Survival in Incident Japanese Hemodialysis Patients

Y. Ohashi, Y. Tomino, H. Hirakata, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

High Target Hemoglobin With Erythropoiesis‐Stimulating Agents Has Advantages in the Renal Function of Non‐Dialysis Chronic Kidney Disease Patients

H. Hirakata, T. Akiba, T. Akizawa, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients.

K. Iseki, T. Shoji, Y. Tsubakihara, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Low Serum Zinc Concentration Is Associated With Infection Particularly in Patients With Stage 5 Chronic Kidney Disease Medicated with Proton Pump Inhibitors.

Yuzo Watanabe, A. Kato, T. Mimura, 2021, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Japanese Society for Dialysis Therapy Clinical Guideline for “Hemodialysis Initiation for Maintenance Hemodialysis”

K. Iseki, J. Minakuchi, H. Hirakata, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2012)

T. Hasegawa, K. Wakai, K. Iseki, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2009)

T. Hasegawa, K. Wakai, K. Iseki, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)

T. Hasegawa, K. Wakai, K. Iseki, 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Overview of Regular Dialysis Treatment in Japan as of 31 December 2006

K. Wakai, K. Iseki, S. Nakai, 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2005)

K. Wakai, K. Iseki, S. Nakai, 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Role of Sevelamer Hydrochloride in the Coronary Artery Calcification Score

K. Maeda, Yuzo Watanabe, Mikiko Fujii, 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

The Most Recent Trends of Peritoneal Dialysis in Japan

K. Iseki, T. Akiba, Y. Tsubakihara, 2008, Peritoneal Dialysis International.

Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study

Yusuke Suzuki, Mina Kato, Tsutomu Inoue, 2022, Scientific Reports.

Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients

S. Fukuhara, K. Aonuma, S. Morita, 2010, Clinical and Experimental Nephrology.

Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact Matching

K. Wakai, K. Iseki, S. Nakai, 2017, Scientific Reports.

Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.

T. Hasegawa, K. Iseki, S. Nakai, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Role of Uremic Toxins and Oxidative Stress in Chronic Kidney Disease

M. Fukagawa, Yuzo Watanabe, 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial

N. Yorioka, Y. Ikari, K. Iseki, 2018, JAMA.

Baseline characteristics and anemia treatment for new hemodialysis patients

Y. Ohashi, Y. Tomino, H. Hirakata, 2008 .

Bacteriological Qualities of Dialysis Fluid in Japan as of 31 December 2006

K. Iseki, T. Akiba, Y. Tsubakihara, 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[Dietary recommendations for chronic kidney disease, 2007].

M. Hattori, T. Nakao, Y. Tsubakihara, 2007, Nihon Jinzo Gakkai shi.

Incidence of Fever of Unknown Origin and Subsequent Antitubercular Medications in Hemodialysis Patients: A Two-Year Prospective Study

N. Hamajima, T. Kawamura, Y. Yuzawa, 2009, Renal failure.

Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy

T. Hasegawa, J. Minakuchi, K. Nitta, 2017, Renal Replacement Therapy.

An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)

Takayuki Hamano, Tetsuo Shoji, Hidetomo Nakamoto, 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Bacteriological Water Quality in the Central Dialysis Fluid Delivery System from the Survey of the Japanese Society for Dialysis Therapy

K. Iseki, S. Nakai, T. Akiba, 2009, Blood Purification.

Thiamine status in end-stage chronic kidney disease patients: a single-center study

Yuzo Watanabe, A. Kato, T. Mimura, 2018, International Urology and Nephrology.

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011)

Takayuki Hamano, Tetsuo Shoji, Hidetomo Nakamoto, 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

A prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM Study

Y. Ohashi, H. Hirakata, T. Akizawa, 2016, Clinical and Experimental Nephrology.

Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large‐Scale Cohort Study (Co‐JET study)

[Case of thrombotic thrombocytopenic purpura with a positive Coomb test].

Y. Yuzawa, S. Matsuo, Yuzo Watanabe, 2005, Nihon Jinzo Gakkai shi.

Proposal for the Shared Decision‐Making Process Regarding Initiation and Continuation of Maintenance Hemodialysis

Peritoneal Dialysis Registry With 2012 Survey Report

T. Hasegawa, K. Wakai, K. Iseki, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Quality of life of elderly patients on peritoneal dialysis versus hemodialysis: a single-center study

Yasuhiko Ito, Yuzo Watanabe, Y. Taniguchi, 2017, Clinical and Experimental Nephrology.

Initiation of renin–angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study

Mina Kato, Tsutomu Inoue, S. Goto, 2023, Clinical and Experimental Nephrology.

Long-Term Proton Pump Inhibitor Therapy Increases the Risk of Infection in Patients with Incident Hemodialysis

Hiroshi Takahashi, Yuzo Watanabe, Y. Saka, 2023, Nephron.

Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large‐Scale Cohort Study (Co‐JET study)